Home/Filings/4/0001209191-16-145134
4//SEC Filing

ALDER BIOPHARMACEUTICALS INC 4

Accession 0001209191-16-145134

CIK 0001423824operating

Filed

Oct 4, 8:00 PM ET

Accepted

Oct 5, 6:54 PM ET

Size

11.4 KB

Accession

0001209191-16-145134

Insider Transaction Report

Form 4
Period: 2016-10-03
Schatzman Randall C
DirectorPresident and CEO
Transactions
  • Sale

    Common Stock

    2016-10-03$31.55/sh2,700$85,189114,768 total
  • Exercise/Conversion

    Common Stock

    2016-10-03$1.26/sh+8,181$10,349122,949 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2016-10-038,1810 total
    Exercise: $1.26Exp: 2017-11-13Common Stock (8,181 underlying)
  • Sale

    Common Stock

    2016-10-03$30.95/sh5,481$169,622117,468 total
Footnotes (5)
  • [F1]The stock option exercise reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 4, 2015.
  • [F2]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 4, 2015.
  • [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.35 to $31.33, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 3 to this Form 4.
  • [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.36 to $32.10, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 4 to this Form 4.
  • [F5]The shares subject to this stock option are fully vested.

Issuer

ALDER BIOPHARMACEUTICALS INC

CIK 0001423824

Entity typeoperating

Related Parties

1
  • filerCIK 0001423824

Filing Metadata

Form type
4
Filed
Oct 4, 8:00 PM ET
Accepted
Oct 5, 6:54 PM ET
Size
11.4 KB